Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4+ T cell responses

被引:96
|
作者
Chambers, CA [1 ]
Kuhns, MS [1 ]
Allison, JP [1 ]
机构
[1] Univ Calif Berkeley, Howard Hughes Med Res Inst, Canc Res Lab, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA
关键词
CD152; inhibitory costimulation; homeostasis; tolerance;
D O I
10.1073/pnas.96.15.8603
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
CTLA-4-deficient mice develop a fatal lymphoproliferative disorder, characterized by polyclonal expansion of peripheral lymphocytes. To examine the effect of restricting the CD4(+) TCR repertoire on the phenotype of CTLA-4-deficient mice and to assess the influence of CTLA-4 on peptide-specific CD4(+) T cell responses in vitro, an MHC class II-restricted T cell receptor (AND TCR) transgene was introduced into the CTLA-4(-/-) animals. The expression of the AND TCR transgene by CD4(+) T cells delays but does not prevent the lymphoproliferation in the CTLA-4(-/-) mice. The CD4(+) T cells become preferentially activated and expand. Interestingly, young AND TCR+ CTLA-4(-/-) mice carrying a null mutation in the rag-1 gene remain healthy and the T cells maintain a naive phenotype until later in life. We demonstrate that CTLA-4 regulates the peptide-specific proliferative response generated by naive and previously activated AND TCR+ RAG(-/-) T cells in vitro. The absence of CTLA-4 also augments the responder frequency of cytokine-secreting AND TCR+ RAG(-/-) T cells. These results demonstrate that CTLA-4 is a keg regulator of peptide specific CD4(+) T cell responses and support the model that CTLA-4 plays a differential role in maintaining T cell homeostasis of CD4(+) vs. CD8(+) T cells.
引用
收藏
页码:8603 / 8608
页数:6
相关论文
共 50 条
  • [21] Role of the immunoglobulin constant region in the antitumor activity of antibodies to cytotoxic T-lymphocyte antigen-4 (CTLA-4)
    Korman, Alan J.
    Engelhardt, John
    Shahabi, Vafa
    Yordanova, Roumyana
    Henning, Karla
    Chen, Timothy
    Selby, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) - A novel strategy for the treatment of melanoma and other malignancies
    O'Day, Steven J.
    Hamid, Omid
    Urba, Walter J.
    CANCER, 2007, 110 (12) : 2614 - 2627
  • [23] Cytotoxic T Lymphocyte Antigen-4 (CTLA4) Haploinsufficiency with no Hypogammaglobulinemia: Case Report
    Vaccari, C.
    Botelho, F.
    Gaggini, L. B.
    Laranjeira, M.
    Catapani, A. N.
    Ueta, S. M.
    Torgerson, T.
    Segundo, G.
    Grumach, A. S.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S25 - S25
  • [24] A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients
    Kemp, EH
    Ajjan, RA
    Husebye, ES
    Peterson, P
    Uibo, R
    Imrie, H
    Pearce, SHS
    Watson, PF
    Weetman, AP
    CLINICAL ENDOCRINOLOGY, 1998, 49 (05) : 609 - 613
  • [25] Unexpected Oral Lesions in a Patient with a Novel Cytotoxic T-lymphocyte Antigen-4 (CTLA-4) Variant - A Case Report
    Rauscher, Christine
    Reyes-Mugica, Miguel
    Cassidy, Elaine
    Shupak, Raymond
    Zhang, Xiaoyi
    Chong, Hey
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S1 - S2
  • [26] Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) Exon 1 A/G polymorphism in Iranian patients with multiple sclerosis
    Borhani-Haghighi, A.
    Ghahramani, S.
    Azarpira, N.
    Pourjafar, M.
    Safari, A.
    JOURNAL OF NEUROLOGY, 2008, 255 : 176 - 176
  • [27] The association between cytotoxic T lymphocyte antigen-4 (CTLA-4) A49G polymorphism and autoimmune blood diseases
    Akturk, F.
    Hancer, V. S.
    Guvenc, S.
    Diz-Kucukkaya, R.
    FEBS JOURNAL, 2006, 273 : 274 - 274
  • [28] Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma
    Monne, M
    Piras, G
    Palmas, A
    Arru, L
    Murineddu, M
    Latte, G
    Noli, A
    Gabbas, A
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 76 (01) : 14 - 18
  • [29] Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) exon 1 A/G polymorphism in Iranian patients with multiple sclerosis
    Borhani-Haghighi, Afshin
    Ghahramani, Sulmaz
    Azarpira, Negar
    PourJafar, Mehrzad
    Nikseresht, Alireza
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (01) : 138 - 138
  • [30] Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity CD8+ T cells independently of CD4+ T cell help
    McCoy, KD
    Hermans, IF
    Fraser, JH
    Le Gros, G
    Ronchese, F
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07): : 1157 - 1162